Stella Pharma Corporation (TYO:4888)
Japan · Delayed Price · Currency is JPY 713.00
-37.00 (-4.93%)
Apr 17, 2026, 3:30 PM JST
Stella Pharma Market Cap
Stella Pharma has a market cap or net worth of 24.27 billion as of April 17, 2026. Its market cap has increased by 76.05% in one year.
Market Cap
24.27B
Enterprise Value
22.36B
Revenue
968.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
713.00
Market Cap Chart
Since April 22, 2021, Stella Pharma's market cap has increased from 23.73B to 24.27B, an increase of 2.26%. That is a compound annual growth rate of 0.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2026 | 24.27B | 251.23% |
| Dec 30, 2025 | 6.91B | -62.20% |
| Dec 30, 2024 | 18.28B | 105.37% |
| Dec 29, 2023 | 8.90B | -22.42% |
| Dec 30, 2022 | 11.47B | -56.48% |
| Dec 30, 2021 | 26.35B | 11.06% |
| Apr 22, 2021 | 23.73B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Healios K.K. | 49.95B |
| Japan Tissue Engineering | 24.65B |
| AnGes | 22.55B |
| RaQualia Pharma | 22.27B |
| Renascience | 19.54B |
| StemRIM | 19.49B |
| ReproCELL | 17.11B |
| CanBas | 14.22B |